Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Jin Kim

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|September 6, 2011
Immunoadsorption for haemolytic uraemic syndromeJon Jin Kim
Pediatric Nephrology (Berlin, Germany)|July 27, 2014
HLA sensitisation: can it be prevented?Lesley Rees, Jon Jin Kim
Archives of Disease in Childhood|November 26, 2009
QUESTION 2. Does nephrocalcinosis in ex-premature babies cause long-term renal problems?Jon Jin Kim, Samir Amin
Clinics (Sao Paulo, Brazil)|May 27, 2014
Long-term outcomes of children after solid organ transplantationJon Jin Kim, Stephen D Marks
Clinical Kidney Journal|June 13, 2015
Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysisJon Jin Kim, Simon C Waller, Christopher J Reid
Drug Design, Development and Therapy|August 14, 2012
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapiesLindsay S Keir, Stephen D Marks, Jon Jin Kim
Pediatric Nephrology (Berlin, Germany)|December 11, 2019
Does HLA matching matter in the modern era of renal transplantation?Jon Jin Kim, Susan V Fuggle, Stephen D Marks
Frontiers in Pediatrics|December 11, 2023
How to know when little kidneys are in trouble: a review of current tools for diagnosing AKI in neonatesRebecca E Evans, Jennifer Peterson, Jon Jin Kim, et al.
JPGN Reports|May 19, 2023
Safety, Tolerability, and Pharmacokinetics of Oral Ferric Maltol in Children With Iron Deficiency: Phase 1 StudyStephen Allen, Marcus Karl-Heinz Auth, Jon Jin Kim, et al.
Pediatric Nephrology (Berlin, Germany)|July 1, 2011
Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutationsJon Jin Kim, Tim H J Goodship, Jane Tizard, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|September 6, 2011
Immunoadsorption for haemolytic uraemic syndromeJon Jin Kim
Pediatric Nephrology (Berlin, Germany)|July 27, 2014
HLA sensitisation: can it be prevented?Lesley Rees, Jon Jin Kim
Archives of Disease in Childhood|November 26, 2009
QUESTION 2. Does nephrocalcinosis in ex-premature babies cause long-term renal problems?Jon Jin Kim, Samir Amin
Clinics (Sao Paulo, Brazil)|May 27, 2014
Long-term outcomes of children after solid organ transplantationJon Jin Kim, Stephen D Marks
Clinical Kidney Journal|June 13, 2015
Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysisJon Jin Kim, Simon C Waller, Christopher J Reid
Drug Design, Development and Therapy|August 14, 2012
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapiesLindsay S Keir, Stephen D Marks, Jon Jin Kim
Pediatric Nephrology (Berlin, Germany)|December 11, 2019
Does HLA matching matter in the modern era of renal transplantation?Jon Jin Kim, Susan V Fuggle, Stephen D Marks
Frontiers in Pediatrics|December 11, 2023
How to know when little kidneys are in trouble: a review of current tools for diagnosing AKI in neonatesRebecca E Evans, Jennifer Peterson, Jon Jin Kim, et al.
JPGN Reports|May 19, 2023
Safety, Tolerability, and Pharmacokinetics of Oral Ferric Maltol in Children With Iron Deficiency: Phase 1 StudyStephen Allen, Marcus Karl-Heinz Auth, Jon Jin Kim, et al.
Pediatric Nephrology (Berlin, Germany)|July 1, 2011
Plasma therapy for atypical haemolytic uraemic syndrome associated with heterozygous factor H mutationsJon Jin Kim, Tim H J Goodship, Jane Tizard, et al.
Pageof 4